Kristen Daniels

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

David Brown, Kazuyuki Nakagome, Joachim Cordes et al. · Schizophrenia Bulletin · 2018 · 42 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Efficacy and Safety of Linagliptin in Black/African American Patients with Type 2 Diabetes: A 6-Month, Randomized, Double-Blind, Placebo-Controlled Study

James Thrasher, Kristen Daniels, Sanjay Patel et al. · Endocrine Practice · 2013 · 20 citations

Medicine, Endocrinology, Pharmacology +14

A randomized Phase <scp>II</scp> trial evaluating efficacy, safety, and tolerability of oral <scp>BI</scp> 409306 in attenuated psychosis syndrome: Design and rationale

Richard S.E. Keefe, Scott W. Woods, Tyrone D. Cannon et al. · Early Intervention in Psychiatry · 2020 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Black/African American patients with type 2 diabetes mellitus: study design and baseline patient characteristics from a randomized clinical trial of linagliptin

James Thrasher, Kristen Daniels, Sanjay Patel et al. · Expert Opinion on Pharmacotherapy · 2012 · 10 citations

Medicine, Internal Medicine, Pharmacology +17